Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Remi Meds vs Trimi

Remi Meds
Graded #493

Lower grade

vs+38.00000000000001
Trimi
Graded #7

Higher grade

The verdict

Trimi takes it — 86.4/100 to 48.4/100.

Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTrimi +59
34
93
Dose & formulationTrimi +30
54
84
Clinical oversightTrimi +28
54
82
Labs & monitoringTrimi +33
50
83
FulfillmentTrimi +37
53
90
Contract termsTrimi +29
55
84
Remi Meds · left barTrimi · right bar

The numbers

MetricRemi MedsTrimi
WeighScore48.4/10086.4/100
GradeCB
Scorecard rank#493#7
Semaglutide$249/mo (0.25 mg dose, compounded)$129/mo
Tirzepatide$349/mo (2.25 mg dose, compounded)$199/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Remi Meds

Graded #493 · C

Strengths

  • Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers
  • LegitScript verification badge on the homepage
  • Publishes 503A FDCA compliance language on the tirzepatide page
  • Per-dose-tier pricing fully shown — no 'as low as' floor-only obfuscation
  • Operating corporate entity disclosed (T-C Health Co)

Where it loses points

  • No named medical director, founder, or physician on any public page
  • States served not listed — 'nationwide' claim with no per-state detail
  • Clinical care runs through Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 companies (Remi Meds itself not FDA-warned)
  • Year founded and corporate history are opaque
  • Two phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure
Trimi

Graded #7 · B

Strengths

  • Low flat pricing on both semaglutide and tirzepatide
  • Both molecules on a single membership
  • Free shipping to all 50 states
  • Fast dispatch once the prescriber signs off

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • Injection only — no oral or sublingual route
  • Dispensing pharmacy not publicly named
  • Shorter public track record than the incumbents

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard